Found 11 matching trials
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation PHASE3 The purpose of this study is to compare the efficacy, safety, and tolerabil...
Show More Status
Active Not Recruiting
Location
Local Institution - 0131
Learn More & Join Trial
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) PHASE3 This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Show More Location
Local Institution - 109
Learn More & Join Trial
Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release N/A This study is designed to evaluate the safety and efficacy of nonconforming...
Show More Location
Multiple Locations
Learn More & Join Trial
Longterm Follow-up of Subjects Treated With bb2121 N/A This is a multi-center, non-randomized, open label, longterm safety and eff...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma PHASE2 This is an open label, single-arm, multicenter, Phase 2 study to evaluate t...
Show More Location
Local Institution - 108
Learn More & Join Trial
A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) PHASE1 This is a multicenter, open-label, phase 1, single arm study intended to de...
Show More Location
Local Institution - 119
Learn More & Join Trial
Study of bb2121 in Multiple Myeloma PHASE1 Study CRB-401 is a 2-part, non-randomized, open label, multi-site Phase 1 s...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant PHASE2 The purpose of this study is to see if the quality of T cells used to creat...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma PHASE2 This study is a multi-cohort, open-label, multicenter Phase 2 study to eval...
Show More Location
Mayo Clinic in Arizona - Scottsdale
Learn More & Join Trial
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma PHASE2 This study is designed as a Phase II, multicenter, single arm trial to asse...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial